Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Herbalife Third Quarter Sales Spurred By 20% Gain In The Americas

This article was originally published in The Tan Sheet

Executive Summary

Herbalife International recorded a 12.1% increase in net sales to $238.9 mil. in the third quarter, boosted by a strong performance in the Americas. The Asia/Pacific Rim segment recorded growth in the quarter as well, but Europe was flat. Herbalife plans to begin operating in India Nov. 10, bringing the number of countries in which it sells its products to 45.

You may also be interested in...

Natrol Prolab buy

Supplement marketer Natrol enters sports fitness market with acquisition of Prolab Nutrition, a seller of sports nutrition products for bodybuilders through gyms, health food stores and other outlets. Natrol is paying $29 mil. cash and 124,270 shares of common stock for the company. Bloomfield, Conn.-based Prolab is expected to post over $30 mil. in sales for 1999. Chatsworth, Calif.-based Natrol plans to assist Prolab with manufacturing, purchasing and product/sales channel development, while Prolab will help enhance Natrol's international sales with its leading market position in Canada and presence in the U.K. and Germany, the firms say. Prolab is expanding its 32,000 sq. ft. distribution facility by 20,000 sq. ft. in the coming months

Herbalife CEO To Purchase All Remaining Stock, Take Company Private

Herbalife International CEO and founder Mark Hughes will be buying all the company's remaining Class A and Class B shares, the firm announced Sept. 13.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts